Pharmaceutical compositions comprising LTV-17 and beta-lactamase inhibitors and their use as antibacterial agents
Abstract:
Pharmaceutical combinations of LTV-17 (I), a lactivicin derivative, and β-lactamase inhibitors are provided, wherein the combinations comprise antibacterial agents suitable for use in the treatment or prevention of bacterial infections.
Information query
Patent Agency Ranking
0/0